These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9589258)

  • 1. Lispro insulin is suitable for external pumps but not for implantable pumps.
    Demirdjian S; Bardin C; Savin S; Zirinis P; Chast F; Slama G; Sélam JL
    Diabetes Care; 1998 May; 21(5):867-8. PubMed ID: 9589258
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe insulin resistance treated with insulin lispro.
    Gill G; Williams G
    Lancet; 1997 Jan; 349(9046):211. PubMed ID: 9111571
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact on clinical status and quality of life of switching from regular insulin to insulin lispro among patients using insulin pumps.
    Campbell RK; Sclar DA; Robison LM; Stowers JK; Ferguson JC; Trippe BS; Kayne DM
    Diabetes Educ; 1998; 24(1):95-9. PubMed ID: 9526330
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe antibody-mediated human insulin resistance: successful treatment with the insulin analog lispro. A case report.
    Lahtela JT; Knip M; Paul R; Antonen J; Salmi J
    Diabetes Care; 1997 Jan; 20(1):71-3. PubMed ID: 9028697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannula occlusion with use of insulin lispro and insulin infusion system.
    Wright AW; Little JA
    Diabetes Care; 1998 May; 21(5):874-5. PubMed ID: 9589263
    [No Abstract]   [Full Text] [Related]  

  • 6. Intensive insulin therapy and insulin pumps.
    Bode BW
    Postgrad Med; 2002 Nov; 112(5 Suppl Designer):17-21. PubMed ID: 19667601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2009 resource guide. Insulin pumps. Some people with diabetes use wearable pumps to provide their insulin.
    Diabetes Forecast; 2009 Jan; 62(1):49-52. PubMed ID: 19445086
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic decompensation in pump users due to lispro insulin precipitation.
    Wolpert HA; Faradji RN; Bonner-Weir S; Lipes MA
    BMJ; 2002 May; 324(7348):1253. PubMed ID: 12028980
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmaceutical development and clinical experiment of new antidiabetic drugs, premixed preparations of insulin lispro (Humalog Mix 25 and Humalog Mix 50) and intermediate-acting insulin lispro (Humalog N)].
    Awa T; Nakata T; Shigeta H
    Nihon Yakurigaku Zasshi; 2005 Aug; 126(2):143-51. PubMed ID: 16205018
    [No Abstract]   [Full Text] [Related]  

  • 10. Stability of insulin lispro in insulin infusion systems.
    Lougheed WD; Zinman B; Strack TR; Janis LJ; Weymouth AB; Bernstein EA; Korbas AM; Frank BH
    Diabetes Care; 1997 Jul; 20(7):1061-5. PubMed ID: 9203437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin Pumps.
    Pickup JC
    Diabetes Technol Ther; 2018 Feb; 20(S1):S30-S40. PubMed ID: 29437475
    [No Abstract]   [Full Text] [Related]  

  • 12. Basal insulin glargine vs prandial insulin lispro in type 2 diabetes.
    Oliveira JH; Kazda C; Simpson A; Jackson JA; Heine RJ
    Lancet; 2008 Aug; 372(9636):371-2; author reply 372. PubMed ID: 18675683
    [No Abstract]   [Full Text] [Related]  

  • 13. Mixing insulin lispro and ultralente insulin.
    Bastyr EJ; Holcombe JH; Anderson JH; Clore JN
    Diabetes Care; 1997 Jun; 20(6):1047-8. PubMed ID: 9167130
    [No Abstract]   [Full Text] [Related]  

  • 14. On calculating treatment satisfaction.
    Bradley C
    Diabetes Care; 1999 Oct; 22(10):1760. PubMed ID: 10526762
    [No Abstract]   [Full Text] [Related]  

  • 15. Closing the Loop.
    Nimri R; Audon P; Pinsker JE; Dassau E
    Diabetes Technol Ther; 2018 Feb; 20(S1):S41-S54. PubMed ID: 29437478
    [No Abstract]   [Full Text] [Related]  

  • 16. Premixed formulations of insulin lispro. Activity profiles in type 1 diabetic patients.
    Rave K; Heinemann L; Puhl L; Gudat U; Woodworth JR; Weyer C; Heise T
    Diabetes Care; 1999 May; 22(5):865-6. PubMed ID: 10332707
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM.
    Attia N; Jones TW; Holcombe J; Tamborlane WV
    Diabetes Care; 1998 May; 21(5):817-21. PubMed ID: 9589247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin confusion: an observation.
    Phillips W; Lando H
    Diabetes Care; 2002 Jun; 25(6):1103-4. PubMed ID: 12032129
    [No Abstract]   [Full Text] [Related]  

  • 19. Lispro insulin: adsorption and stability in selected intravenous devices.
    Ling J; Hu M; Hagerup T; Campbell RK
    Diabetes Educ; 1999; 25(2):237-45. PubMed ID: 10531849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable insulin pumps.
    Selam JL
    Lancet; 1999 Jul; 354(9174):178-9. PubMed ID: 10421296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.